Therapeutic applications targeting glutamate receptors are a growing area of research. Drugs that modulate these receptors can potentially treat various neurological disorders. For instance, NMDA receptor antagonists are being investigated for their potential to reduce excitotoxicity in stroke and traumatic brain injury. Additionally, AMPA receptor modulators are being studied for their role in enhancing cognitive function in Alzheimer's disease.
